Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Renmin Tongtai Pharmaceutical is a prominent Chinese pharmaceutical commercial enterprise primarily engaged in the wholesale and retail of drugs and medical devices. Based in Harbin, Heilongjiang Province, the company operates as a key subsidiary of the Harbin Pharmaceutical Group (Hayao). Its retail arm, "Renmin Tongtai," is one of the most recognized pharmacy brands in Northeast China, managing an extensive network of chain stores. The company's wholesale division provides comprehensive distribution services to hospitals and medical institutions across the region. Listed on the Shanghai Stock Exchange, it focuses on optimizing its supply chain and expanding its healthcare service offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Renmin Tongtai Pharmaceutical.